If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquis Exchange Regulatory News (AQX)

Share Price Information for Aquis Exchange (AQX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 468.00
Bid: 460.00
Ask: 470.00
Change: 3.00 (0.65%)
Spread: 10.00 (2.174%)
Open: 465.00
High: 468.00
Low: 468.00
Prev. Close: 465.00
AQX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Minority Interest

7 Aug 2023 14:15

RNS Number : 5390I
Aquis Exchange PLC
07 August 2023
 

7 August 2023

 

Aquis Exchange PLC

("Aquis", the "Company" or the "Group")

 

Acquisition of minority interest in OptimX Markets Inc.

 

Aquis Exchange PLC (AQX.L), announces that on 7 August 2023 it acquired a minority stake in OptimX Markets Inc. (OptimX) a, US-based financial services start-up focused on the block trading market (the "Investment").

 

Created by a team of experienced equity capital markets professionals led by David Barnett, OptimX's advanced technology suite will offer investment banks, brokers and institutions the opportunity to find additional matches for order flow. Aquis will work closely with OptimX in the UK and EU combining its market-leading technology platform with the OptimX technology suite. This initiative will further expand the product suite available to Aquis members reinforcing the innovative approach Aquis brings to capital markets.

 

The Investment was made as part of a consortium which includes DB1 Ventures, the venture capital arm of Deutsche Boerse Group.

 

The Investment is split into two tranches: Aquis will subscribe US$0.75m out of a total first tranche of US$3.0m payable in cash, followed by a second tranche in 12 months of a further US$0.75m out of a total $3.0m payable in cash. The pre-money valuation of the first tranche was US$10m and the valuation for the second tranche will be finalised at the date of investment.

 

It is expected that Jonathan Clelland, COO of Aquis, will join the board of OptimX as a Non-Executive Director in due course.

 

OptimX is a new venture and so has not yet generated any profits or losses.

 

Aquis CEO, Alasdair Haynes said:

 

"The investment in OptimX is a significant opportunity for Aquis, adding additional connectivity to our successful dark pool (the Aquis Matching Pool) and providing clients with the ability to cross large blocks. This alongside Aquis's growing functionality will further enhance the range of execution options available to our members."

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR")

 

 

Enquiries:

 

Aquis Exchange PLC

Tel: +44 (0)20 3597 6321

Alasdair Haynes, CEO

Richard Fisher, CFO

Adele Gilbert, Head of Marketing

 

Tel: +44 (0)20 3597 6329

VSA Capital Limited (AQSE Corporate Adviser)

Tel: +44(0)20 3005 5000

Andrew Raca

 

Liberum Capital Limited (Nominated Adviser and Broker)

Tel: +44 (0)20 3100 2000

Clayton Bush

Chris Clarke

Edward Thomas

Kane Collings

 

Canaccord Genuity Limited (Joint Broker)

Emma Gabriel

Patrick Dolaghan

 

 

 

 

Tel: +44 (0) 20 7523 8000

Alma PR (Financial PR Adviser)

Tel: +44 (0)20 3405 0209

Josh Royston

aquis@almapr.co.uk

Kieran Breheny

 

Pippa Crabtree

 

 

Notes to editors:

 

About Aquis Exchange PLC

Aquis Exchange PLC ("Aquis") is a creator and facilitator of next-generation financial markets, through the provision of accessible, simple and efficient stock exchanges, trading venues and technology.

Aquis consists of three divisions: Aquis Markets, a subscription-based exchange offering pan-European cash equities trading; Aquis Technologies, which develops and licenses next-generation exchange technology globally; and Aquis Stock Exchange, a growth and regulated primary exchange delivering capital to companies via the listing and trading of shares.

Aquis Markets operates lit and dark order books, covering 16 European markets. For its lit books, Aquis uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade and does not allow aggressive non-client proprietary trading, which has resulted in lower market impact and signalling risk on Aquis than other trading venues in Europe.

Aquis Technologies is the software and technology division of Aquis. It focuses on building better markets via the creation and licensing of cutting-edge, cost-effective exchange infrastructure technology and services, including matching engine and trade surveillance solutions.

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is authorised as a Recognised Investment Exchange, which allows it to operate a regulated listings venue. The AQSE Growth Market is divided into two segments 'Access' and 'Apex', with different levels of admission criteria. The Access market focuses on earlier stage growth companies, while Apex is the intended market for larger, more established businesses.

Aquis is authorised and regulated by the UK Financial Conduct Authority and France's Autorité de contrôle prudentiel et de résolution and Autorité des Marchés Financiers to operate Multilateral Trading Facility businesses in the UK & Switzerland markets and in EU27 markets respectively. Aquis Exchange PLC is quoted on the Aquis Stock Exchange and on the Alternative Investment Market of the LSE (AIM) market. For more information, please go to www.aquis.eu.

 

About OptimX Markets Inc: OptimX Markets Inc. forges a new dynamic in institutional trading by restoring transparency and simplicity to sourcing block trades. Committed to preserving the fragile ecosystem between brokers and institutional investors in financial transactions, OptimX believes that great technology should enhance relationships rather than replace them, ensuring a seamless experience for both consumers and providers of liquidity. OptimX offers unique and comprehensive trading solutions in both US and EMEA capital markets. For more information, please go to www.optimx.com

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQUBROROOUWRAR
Date   Source Headline
24th Apr 20207:00 amRNSPublication of ARA and Notice of AGM
20th Apr 20207:00 amRNSIssue of Options and Director/PDMR Notification
16th Apr 20207:00 amRNSFinal results
15th Apr 20207:00 amRNSExercise of Share Options & Total Voting Rights
24th Mar 20207:00 amRNSUpdate to Results Announcement Date
4th Mar 20203:49 pmRNSFCA Approval of NEX Exchange Acquisition
19th Dec 20197:00 amRNSTiming of NEX Exchange Acquisition,Trading Update
22nd Nov 20192:40 pmRNSDirector/PDMR Notification
17th Sep 20197:00 amRNSInterim results for six months ended 30 June 2019
28th Aug 20197:00 amRNSNotice of Results
5th Jul 20197:00 amRNSAcquisition of NEX Exchange
27th Jun 20195:57 pmRNSMarket Update
5th Jun 20197:00 amRNSAquis Exchange achieves record market share
30th Apr 20191:16 pmRNSResult of AGM
29th Mar 20197:00 amRNSPublication of Annual Report and Notice of AGM
20th Mar 20191:30 pmRNSConfirmation of Board Appointment
20th Mar 20197:00 amRNSFinal Results for the year ended 31 December 2018
5th Mar 201911:00 amRNSAquis supplies AkinovA with trading technology
26th Feb 20194:38 pmRNSTR-1: Notification of major holdings
19th Feb 20197:00 amRNSTR-1: Notification of major holdings
24th Jan 20197:00 amRNSFrench Regulatory Approval
8th Jan 20197:00 amRNSTrading Update and Board Appointment
7th Jan 20192:14 pmRNSTR-1: Notification of major holdings
4th Dec 201811:13 amRNSAQUIS EXCHANGE RELEASE NOVEMBER TRADING STATISTICS
26th Nov 201811:10 amRNSStandard form for notification of major holdings
21st Nov 201810:17 amRNSDirector/PDMR Notification
16th Oct 20189:54 amRNSTR-1: Notification of major holdings
25th Sep 20187:00 amRNSInterim Results for six months ended 30 June 2018
6th Sep 20187:00 amRNSTechnology Licensing Agreement
4th Sep 20185:19 pmRNSResult of General Meeting
13th Aug 20185:15 pmRNSNotice of General Meeting
4th Jul 20183:59 pmRNSTR-1: Notification of major holdings
14th Jun 20188:30 amRNSDirector/PDMR Shareholding
14th Jun 20187:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.